New short on $ARKG at $47.40 — first tranche in.
One of the biggest AI myths right now is that hallucinating chatbots are somehow going to cure cancer and magically turn money-bleeding genomics stocks profitable. Not happening.
$ARKG ran over 100% from June to early October this year. Classic melt-up. Now it's time to give it all back.
Shorting here at $47.40. First tranche locked. More to come if the setup holds.
One of the biggest AI myths right now is that hallucinating chatbots are somehow going to cure cancer and magically turn money-bleeding genomics stocks profitable. Not happening.
$ARKG ran over 100% from June to early October this year. Classic melt-up. Now it's time to give it all back.
Shorting here at $47.40. First tranche locked. More to come if the setup holds.